STAAR Surgical (STAA)
(Delayed Data from NSDQ)
$48.19 USD
+1.66 (3.57%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $48.26 +0.07 (0.15%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Balance Sheet
Fiscal Year End for STAAR Surgical Company falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 221 | 212 | 200 | 152 | 120 |
Receivables | 95 | 62 | 44 | 35 | 31 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 35 | 24 | 17 | 18 | 17 |
Other Current Assets | 15 | 13 | 11 | 11 | 7 |
Total Current Assets | 365 | 312 | 271 | 216 | 175 |
Net Property & Equipment | 67 | 51 | 36 | 24 | 17 |
Investments & Advances | 12 | 14 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 5 | 5 | 4 | 5 | 4 |
Intangibles | 2 | 2 | 2 | 2 | 2 |
Deposits & Other Assets | 3 | 1 | 1 | 1 | 1 |
Total Assets | 489 | 415 | 346 | 257 | 207 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 1 | 2 |
Accounts Payable | 14 | 12 | 9 | 8 | 8 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 1 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 47 | 36 | 37 | 29 | 21 |
Total Current Liabilities | 65 | 52 | 49 | 41 | 34 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1 | 1 | 1 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 5 | 2 | 9 | 12 | 8 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 103 | 83 | 87 | 60 | 47 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 437 | 404 | 374 | 338 | 304 |
Retained Earnings | -47 | -73 | -111 | -136 | -142 |
Other Equity | -4 | 0 | -4 | -6 | -3 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 386 | 332 | 259 | 197 | 160 |
Total Liabilities & Shareholder's Equity | 489 | 415 | 346 | 257 | 207 |
Total Common Equity | 386 | 332 | 259 | 197 | 160 |
Shares Outstanding | 48.80 | 48.20 | 47.60 | 46.10 | 44.50 |
Book Value Per Share | 7.91 | 6.89 | 5.43 | 4.28 | 3.59 |
Fiscal Year End for STAAR Surgical Company falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 221 | 188 | 192 | 204 |
Receivables | NA | 95 | 112 | 94 | 63 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 35 | 31 | 25 | 28 |
Other Current Assets | NA | 15 | 16 | 16 | 18 |
Total Current Assets | NA | 365 | 347 | 328 | 313 |
Net Property & Equipment | NA | 67 | 63 | 56 | 53 |
Investments & Advances | NA | 12 | 14 | 18 | 13 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 5 | 9 | 5 | 5 |
Intangibles | NA | 2 | 2 | 2 | 2 |
Deposits & Other Assets | NA | 3 | 2 | 1 | 1 |
Total Assets | NA | 489 | 472 | 441 | 419 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 14 | 9 | 11 | 9 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 47 | 44 | 39 | 34 |
Total Current Liabilities | NA | 65 | 57 | 54 | 47 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 1 | 1 | 1 | 1 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 3 | 3 | 3 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 103 | 93 | 87 | 80 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 437 | 436 | 420 | 409 |
Retained Earnings | NA | -47 | -55 | -64 | -70 |
Other Equity | NA | -4 | -3 | -3 | -1 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 386 | 379 | 354 | 339 |
Total Liabilities & Shareholder's Equity | NA | 489 | 472 | 441 | 419 |
Total Common Equity | 0 | 386 | 379 | 354 | 339 |
Shares Outstanding | 48.80 | 48.80 | 48.80 | 48.50 | 48.30 |
Book Value Per Share | 0.00 | 7.91 | 7.76 | 7.29 | 7.02 |